Arcturus Therapeutics (ARCT.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Nov24

Arcturus Therapeutics to Participate in Piper Sandler 37th Annual Healthcare Conference and Have a Fireside Chat

21:01

Nov12

BTIG Maintains Buy Rating for Arcturus, with a Target Price of $23

12:02

Arcturus Therapeutics Reports Q3 2025 Revenue Decline

11:26

Nov11

Arcturus Therapeutics released FY2025 Q3 earnings on November 10 After-Market (EST), actual revenue USD 17.15 M (forecast USD 16.03 M), actual EPS USD -0.4946 (forecast USD -0.899)

00:00

Arcturus Therapeutics released FY2025 9-month earnings on November 10 After-Market EST, actual revenue USD 74.83 M, actual EPS USD -1.3522

00:00

Nov3

Arcturus Therapeutics to Release FY2025 Q3 Earnings on November 10 After-Market (EST), Forecast Revenue USD 16.03 M, EPS USD -0.899

00:17

Schedules & Filings

Schedules

Filings

Nov10

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 17.15 M, Net Income -13.45 M, EPS -0.4946

Aug11

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 28.3 M, Net Income -9.18 M, EPS -0.3383

May12

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 29.38 M, Net Income -14.08 M, EPS -0.5192

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More